Association Between Automated Coronary Artery Calcium From Routine Chest Computed Tomography Scans and Cardiovascular Risk in Patients With Colorectal or Gastric Cancer

BACKGROUND: As cardiovascular disease (CVD) is the leading cause of noncancer mortality in colorectal or gastric cancer patients, it is essential to identify patients at increased CVD risk. Coronary artery calcium (CAC) is an established predictor of atherosclerotic CVD; however, its application is limited in this population. This study evaluates the association between automated CAC scoring using chest computed tomography and atherosclerotic CVD risk in colorectal or gastric cancer patients. METHODS: A retrospective cohort study was conducted using electronic health records linked to claims data of colorectal or gastric cancer patients who underwent non-ECG-gated chest computed tomography at 2 tertiary hospitals in South Korea between 2011 and 2019. CAC was automatically quantified using deep learning software and used to classify patients into 4 groups (CAC=0, 0<CAC≤100, 100<CAC≤400, CAC>400). The primary outcome was major adverse cardiovascular events (myocardial infarction, stroke, or cardiovascular mortality), and assessed using the multivariable Fine and Gray subdistribution hazard model. A meta-analysis was performed to calculate pooled subdistribution hazard ratios. RESULTS: A total of 3153 patients were included in this study (36.5% female; 36.3% CAC=0; 38.1% 0<CAC≤100; 14.1% 100<CAC≤400; 11.5% CAC>400). The mean follow-up period was 4.1 years. The incidence rate of MACE was 5.28, 8.03, 9.99, and 29.14 per 1000 person-years in CAC=0, 0<CAC≤100, 100<CAC≤400, and CAC>400. Compared with CAC=0, the risk of MACE was not significantly different in patients with 0<CAC≤100 (subdistribution hazard ratio, 1.43 [95% CI, 0.41–5.01]), and 100<CAC≤400 (subdistribution hazard ratio, 0.99 [95% CI, 0.48–2.04]). Patients with CAC>400 had 2.33 (95% CI, 1.24–4.39) times higher risk of MACE compared with those with CAC=0. CONCLUSIONS: CAC>400 was associated with an increased risk of MACE compared with CAC=0 among colorectal or gastric cancer patients. CAC quantified on routine chest computed tomography scans provides prognostic information for atherosclerotic CVD risk in this population.